Skip to search formSkip to main contentSkip to account menu

Lurasidone Hydrochloride 80 MG Oral Tablet [Latuda]

Known as: LURASIDONE HYDROCHLORIDE 80 mg ORAL TABLET, FILM COATED [Latuda], Latuda 80 MG Oral Tablet 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Purpose/Background The antipsychotic agent lurasidone (Latuda®) is metabolized by Cytochrome P450-3A (CYP3A) enzymes… 
Review
2015
Review
2015
Lurasidone (Latuda®), a benzisothiazole derivative antipsychotic, is approved in the USA and Canada for the treatment of adults… 
Review
2015
Review
2015
▼Lurasidone (Latuda—Sunovion) is a new oral second-generation antipsychotic licensed for treating adults with schizophrenia… 
2013
2013
includes attention and memory deficits and performance deficits. It is also known that these major symptoms often co-occur with… 
2013
2013
  • 2013
  • Corpus ID: 3967222
 Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.  LATUDA… 
2012
2012
Similar to other second-generation antipsychotics, lurasidone is an antagonist at dopamine D2 and serotonin 5HT2A receptors, and… 
Review
2012
Review
2012
Last year, the December issue of the Mental Health Clinician was dedicated to highlighting new psychotropics agents recently… 
Review
2011
Review
2011
Lurasidone was approved by the Food and Drug Administration (FDA) in 2011. This article reviews clinically significant aspects of… 
Review
2011
Review
2011
This article briefly reviews the novel atypical second-generation antipsychotic drugs iloperidone (Fanapt®), asenapine (Saphris…